BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5262681)

  • 1. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute lymphoblastic leukemia in children with L-asparaginase].
    Russo G; Schiliro G
    Pediatria (Napoli); 1971; 79(1):27-51. PubMed ID: 5286091
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of asparaginase in chemotherapy-resistant acute leukemias.
    Goudemand M; Bauters F
    Recent Results Cancer Res; 1970; 33():316-22. PubMed ID: 5292721
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 6. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 8. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

  • 9. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with L-asparaginase.
    Oettgen HF; Tallal L; Tan CC; Murphy ML; Clarkson BD; Golbey RD; Krakoff IH; Karnofsky DA; Burchenal HJ
    Recent Results Cancer Res; 1970; 33():219-35. PubMed ID: 5292718
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with L-asparaginase of renal and testicular involvement in acute lymphoblastic leukemia in children (author's transl)].
    Armata J; Cyklis R; Legutko L
    Acta Paediatr Belg; 1974; 28(1):49-57. PubMed ID: 4526297
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase-induced coagulation abnormalities: report of a case.
    Hensley MF
    J Am Osteopath Assoc; 1983 May; 82(9):680-1. PubMed ID: 6575006
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitization to L-asparaginase during the treatment of lymphoblastic leukosis].
    Popović K; Ilić V; Spevak L
    Srp Arh Celok Lek; 1972 Mar; 100(3):387-90. PubMed ID: 4505679
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
    Zajaczkowski J; Pituch A; Legutko L; Pajak E
    Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary results in the treatment of acute lymphoblastic leukemia in a child with L-asparaginase].
    Massimo L; Cottafava F; Mori PG; Fossati-Guglielmoni A; Dagna-Bricarelli F
    Minerva Pediatr; 1971 Jun; 23(26):1130-6. PubMed ID: 5286311
    [No Abstract]   [Full Text] [Related]  

  • 18. [On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
    Stier HW; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1969 Feb; 94(6):253-60. PubMed ID: 5249235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acquired deficiencies in antithrombin III and C protein during treatment with L-asparaginase].
    Mielot F; Danel P; Boyer C; Coulombel L; Dommergues JP; Tchernia G; Larrieu MJ
    Arch Fr Pediatr; 1987 Mar; 44(3):161-5. PubMed ID: 2883953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.